Arbutus Biopharma Corp Annual Interest Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Arbutus Biopharma Corp quarterly/annual Interest Expense history and growth rate from 2015 to 2023.
  • Arbutus Biopharma Corp Interest Expense for the quarter ending June 30, 2024 was $34K, a 80.1% decline year-over-year.
  • Arbutus Biopharma Corp Interest Expense for the twelve months ending June 30, 2024 was $168K, a 84.8% decline year-over-year.
  • Arbutus Biopharma Corp annual Interest Expense for 2023 was $459K, a 73.4% decline from 2022.
  • Arbutus Biopharma Corp annual Interest Expense for 2022 was $1.73M, a 39.6% decline from 2021.
  • Arbutus Biopharma Corp annual Interest Expense for 2021 was $2.86M, a 28.8% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $459K -$1.27M -73.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $1.73M -$1.13M -39.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $2.86M -$1.15M -28.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $4.01M +$1.9M +90.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 $2.11M +$1.88M +833% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $226K -$35K -13.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $261K +$261K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.